A Randomised Double Blind, Placebo-controlled Study of Nefiracetam in Patients with Post- stroke Apathy

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/634412

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

A wide range of emotional and cognitive disturbances are observed following stroke. Apathy is expressed by diminished initiation and poor persistence on tasks, lack of interest, emotional indifference and low social engagement. Our preliminary study has suggested that the medication nefiracetam significantly improves apathy among stroke patients. The main aim of our project is to conduct a large scale study to determine whether nefiracetam improves apathy in patients with stroke lesions.

Funded Activity Details

Start Date: 01-01-2010

End Date: 01-01-2014

Funding Scheme: Project Grants

Funding Amount: $865,271.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Psychiatry (incl. Psychotherapy)

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

Apathy | Cognitive deficits | Depression | Nefiracetam | Stroke

Related Links